rs730880455
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000169.3(GLA):c.41T>C(p.Leu14Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000169.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
- -
Fabry disease Pathogenic:1
Variant summary: GLA c.41T>C (p.Leu14Pro) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. In addition, nearby variants, A15E, A15G, A15P, L16R, and L16P, has been reported in affected Fabry disease individuals via HGMD, therefore, suggesting the region is important for protein function. The variant was absent in 183408 control chromosomes. c.41T>C has been reported in the literature in individuals from one Chinese family affected with Fabry Disease (Tse_2003) and in at-least one patient in an independent study evaluating the lifetime occurrence of thromboembolic events in a cohort of patients with Fabry Disease (Lenders_2015). The variant has been subseqiently cited by prominent databases (Fabry disease database) and the literature (example, Kuipers_2010). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in significantly reduced (<1%) alpha galactosidase enzyme activity in hemizyous affected males (example, Tse_2003). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at